Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
CHESHIRE, Conn. - Alexion Pharmaceuticals Inc. said Tuesday David Keiser will retire as president and chief operating officer at the end of the year.
| ALXN | 35.8 |  -1.02 |
The company said Keiser's responsibilities would be distributed among Alexion's management team, reporting to Chief Executive Leonard Bell.
Keiser will serve out his term on the company's board of directors, which ends in 2009, and will be available as a consultant for the company.
Keiser joined Alexion in 1992 after 15 years at various pharmaceutical companies, including Hoffmann La Roche and G.D. Searle. He was appointed to the additional role of president in 2002.
Shares of Alexion Pharmaceuticals fell 67 cents to $41.08 in morning trading.
You've heard the talk of "Green" throughout the whole of 2008, bu...
Lenovo, with its IdeaPad line series is previewing Y-Series IdeaPad Y650 laptops at CES in Las Vegas together with other new Ideapad Y-series.
Haywood Securities say metal prices seem oversold and will remain so as long as negative sentiment persists.
Cisco will unveil new consumer products and initiatives during apress conference at the 2009 ...
Get your next web design project done with our los angeles web design team - Best web design with great price.
Building your business and corporate credit for your small business.
Buy Real Estate, Tax Liens, and more- Fund your business or franchise without debt
Partners   
|
© 2009 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
